Protective activity of Geraniol (cas 106-24-1) against acetic acid and Helicobacter pylori- induced gastric ulcers in rats
-
Add time:08/18/2019 Source:sciencedirect.com
Geraniol (cas 106-24-1), an active constituent of rose and palmarosa essential oils, possesses several pharmacological properties, including antioxidant, antibacterial and antiulcer activity. Geraniol was therefore investigated for its antiulcer and anti-Helicobacter pylori activity in rats. Ulcers were induced by injecting acetic acid into the sub-serosal layer of the stomach followed by orogastric inoculation of H. pylori for 7 days. Geraniol (15 and 30 mg/kg), vehicle and a standard drug combination (amoxicillin, 50 mg/kg; clarithromycin, 25 mg/kg and omeprazole, 20 mg/kg) were administered twice daily for 14 days. All the parameters were measured at the end of treatment. The ulcer index was significantly (P < 0.05) lowered in geraniol and standard drug-treated rats as compared to the H. pylori control group (4.13 ± 0.43). Treatment with geraniol (30 mg/kg) significantly (P < 0.01) increased the gastric pH along with a reduction in total acidity and gastric juice volume. Geraniol significantly (P < 0.05) attenuated the myeloperoxidase activity and augmented the total glutathione level in gastric mucosa. The extent of damage in the stomach was measured using a histopathological score. The score in H. pylori control, geraniol (30 mg/kg) and standard drugs was 9, 3.5 and 2.0 respectively. In the rapid urease test, treatment with geraniol (30 mg/kg) and the standard drugs produced a 33% and 67% cure respectively from H. pylori infection. Further, the reduction in bacterial load in the gastric mucosa was confirmed using modified Giemsa staining. Geraniol was observed to exhibit significant antiulcer and anti-H. pylori activity in a rodent model.
We also recommend Trading Suppliers and Manufacturers of Geraniol (cas 106-24-1). Pls Click Website Link as below: cas 106-24-1 suppliers
Prev:High pressure phase behaviour for the CO2 + n-dodecane + 3,7-dimethyl-1-octanol system
Next:The potential of Geraniol (cas 106-24-1) to reduce cytotoxic and genotoxic effects of MNNG in plant and human lymphocyte test-systems) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Transcriptome analysis and targeted metabolic profiling for pathway elucidation and identification of a Geraniol (cas 106-24-1) synthase involved in iridoid biosynthesis from Gardenia jasminoides08/27/2019
- Effect of Geraniol (cas 106-24-1) on performance, emission and combustion characteristics of CI engine fuelled with gutter oil obtained from different sources08/26/2019
- Protective effect of Geraniol (cas 106-24-1) on the transgenic Drosophila model of Parkinson’s disease08/25/2019
- Original articleGeraniol (cas 106-24-1) alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress08/24/2019
- In vitro and in vivo biofilm inhibitory efficacy of Geraniol (cas 106-24-1)-cefotaxime combination against Staphylococcus spp.08/23/2019
- Thymoquinone and Geraniol (cas 106-24-1) alleviate cisplatin-induced neurotoxicity in rats through downregulating the p38 MAPK/STAT-1 pathway and oxidative stress08/22/2019
- Manipulation of GES and ERG20 for Geraniol (cas 106-24-1) overproduction in Saccharomyces cerevisiae08/21/2019
- Regular articleAn enzyme-coupled assay enables rapid protein engineering for Geraniol (cas 106-24-1) production in yeast08/20/2019
- The potential of Geraniol (cas 106-24-1) to reduce cytotoxic and genotoxic effects of MNNG in plant and human lymphocyte test-systems08/19/2019